Mai Capital Management Northwest Biotherapeutics Inc Call Options Transaction History
Mai Capital Management
- $9.87 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NWBO
# of Institutions
14Shares Held
687KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC462KShares$124,7980.02% of portfolio
-
Opus Capital Group, LLC60.2KShares$16,2400.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$9,4500.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$6,3990.0% of portfolio
-
Lee Danner & Bass Inc20KShares$5,4000.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $280M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...